Latest News
-
Ola Cabs Plans $500 Million IPO Amid Electric Vehicle Expansion -
Daily Relative Strength Index (RSI) In A Bullish Mode of This Pharma Stock; Buy For TP Rs 635-685 -
HDFC Bank Q4 Preview: Net Profit Likely To Grow 56% YoY; Credila Stake Sale To Fuel Earnings -
1:10 Split, Rs 299/Sh Dividend: Tata's Steel Stock Up 11% In 30-Days, Better Than Nifty; PL Says Accumulate -
625% Dividend, 1:10 Split, 3 Bonus; FMCG ITC Makes Big Acquisition Announcement; Stock Target Prices In April -
2:1 Bonus Issue: IT Penny Stock Turned; 1,600 Shares Market Lot Size Revised To 4,800 Shares -
FREE, FREE, FREE! 3:1 Bonus: Pharma Stock Hits Back-To-Back Upper Circuits; 500 Shares To Earn Rs 1,69,500 -
1:10 Stock Split: Below Rs 10, Fertilizer Sector Turned Ex-Split; 8,282% Returns In 5 Years -
Rs 17/Share Dividend: Record Date On April 26; Buy The ICICI Group Stock To Be Eligible? -
Honasa Consumer to Strengthen Operations by Merging Fusion Cosmeceutics and Just4Kids
For Daily Alerts
AstraZeneca Pharma shares tumble on patent loss
Shares of the company were last traded at Rs 1500, down 4% on the Bombay Stock Exchange.
AstraZeneca in India has its Research and Development,Manufacturing and Marketing offices in Bangalore,operating through two companies: AstraZeneca Pharma India Limited (AZPIL), involved in Manufacturing and Marketing, and AstraZeneca India Private Limited (AZIPL),involved in Research and Development,Pharmaceutical Research & Development and Branded Generics.
GoodReturns.in
Story first published: Thursday, November 29, 2012, 10:40 [IST]
